Dipivefrin

Description

Dipivefrin is used for the treatment of increased fluid pressure inside the eye (intraocular hypertension) and open-angle glaucoma, a progressive condition that may eventually lead to vision loss. This medicine is not recommended for use in patients below 18 years of age.

Side effects

Major & minor side effects for Dipivefrin

  • Rapid or irregular heartbeat
  • Skin rash
  • Blurred vision
  • Headache
  • Dizziness
  • Burning and stinging of eye
  • Eye irritation
  • Eye pain
  • Eye redness
  • Sensitivity to light

Uses of Dipivefrin

What is it prescribed for?

  • Open-angle glaucoma
  • Intraocular hypertension
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to show its action is not clinically established.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition. If the medicine is used, monitor the infant closely for any adverse effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to dipivefrin, epinephrine, or any other inactive ingredients present along with this medicine.

Narrow-angle glaucoma

This medicine is not recommended for use in patients with narrow-angle glaucoma due to the risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may prescribe a safer alternative based on your clinical condition. If the medicine is used, monitor the infant closely for any adverse effects.
General warnings

Driving or operating machines

This medicine may cause blurred vision in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience this symptom during treatment with this medicine.

Contact lens

This medicine is not recommended for use if you are wearing soft contact lenses in your eyes. The lens should be removed prior to administration of the eye drops and can be reinserted after 15 minutes of administration.

Use in children

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established. However, your doctor may prescribe this medicine if the benefits significantly outweigh the risks. In such a case, the patient should be monitored closely for any adverse effects.

Bacterial keratitis

If the ophthalmic solution of this medicine is contaminated by bacteria, it can lead to an infection of the cornea (bacterial keratitis). Patients are advised to take all hygienic precautions to ensure that the medicine is not contaminated.

Missed Dose

Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Ergotamine

Selegiline

Procarbazine

Disease interactions

Aphakia

This medicine should be used with extreme caution in patients with a condition called Aphakia (absence of lens in the eye) due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Narrow-angle glaucoma

This medicine is not recommended for use in patients with narrow-angle glaucoma due to the increased risk of worsening the patient's condition. An alternative treatment option should be considered based on clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Use this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Effect on sleep is not established

How it works
This medicine works by reducing the pressure inside the eyes.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Ophthalmic glaucoma agents

Schedule

Schedule H

Dipivefrin - DrugBank [Internet]. Drugbank.ca. 2018 [cited 18 December 2018]. Available from:

https://www.drugbank.ca/drugs/DB00449

[Internet]. Accessdata.fda.gov. 2018 [cited 18 December 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18239s25lbl.pdf

Dipivefrin [Internet]. Pubchem.ncbi.nlm.nih.gov. 2019 [cited 14 March 2019]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/dipivefrin

Dipivefrin Ophthalmic: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2019 [cited 14 March 2019]. Available from:

https://medlineplus.gov/druginfo/meds/a686005.html

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 14 Mar 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.